Free Webex Call
The United States Blood Bags market stood at USD 94.85 million in 2021 and is expected to grow at a steady rate of 6.08% during the forecast period. The major factors include increasing prevalence of chronic diseases imposing surgeries, trauma, anemia, myeloma, lymphoma, leukemia, etc., high demand of blood transfusion procedures, and medical advancement. Blood bags are made up of a thin material which contains a plasticizer composition such as dioctyl phthalate which is used for long term collection, storage, separation, and transportation of red blood cells, white blood cells, and platelets. The other factor which is bolstering the market growth are increasing investments in the healthcare sector, growing population awareness, and increase in number of surgeries. Various initiatives regarding blood donation campaigns are taken by government or private organizations, to raise awareness about diseases and treatments, as well as information about the availability of more advanced technologies and procedures at healthcare facilities.Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Rise in Chronic Diseases
The prevalence in number of chronic diseases such as cardiovascular diseases, surgeries, trauma, and injuries either caused due to road accidents or any other accidental or non-accidental reasons resulting in high amount of blood loss which requires additional blood support for treatment of patients and cancer gives rise to increase in the growth of blood bags market. Its trend has been increasing due to lower incision, reduce in timings of hospital stays and lower cost associated with the surgical procedures.Growing Demand of Blood Transfusion Procedures
The main cause of increasing demand for blood transfusion procedures was due to increased demand of blood for the treatment of various severe diseases such as cancer. According to American Cancer Society, more than 1.8 million people were diagnosed with cancer in 2020. They need blood, sometimes daily, during their chemotherapy treatment. For instance, an estimated 1,519,907 people in the United States were suffering from leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS) or myeloproliferative neoplasms (MPNs). Additionally, the injuries caused due to road accidents also requires blood for healing and surgical procedures. Therefore, the high blood disorder rate and huge accidental cases in the United States are expected to drive the blood bags market in the coming years.Medical Advancements
Rapid advancements in research and development (R&D) activities are driving the growth of the market as novel drugs/medications and new products are developed for the treatment of chronic diseases. The new information technology system is developed to reduce the transfusion errors by involving a barcode on patient’s wristband which is matched electronically with blood samples and with the units of blood prepared for transfusion for every patient. Furthermore, the frequent technological advancements for minimal invasive surgical procedures to treat chronic diseases is driving the market growth.Market Segmentation
The United States Blood Bags Market can be segmented into product, type, volume, material, end user, and region. By product, the market can be segmented into single blood bag, double blood bag, triple blood bag, quadruple blood bag, and penta blood bag. Based on type, the market can be split into collection blood bags and transfer blood bags. In terms of volume, the market can be divided into 450ml, 350ml, 150ml, 100ml, 250ml, and Others (400, 500, 200 ml). By material, the market can be fragmented into PVC, PET, and others. Based on end user, the market can be differentiated into hospitals & clinics, ambulatory care centers, blood banks, and others.Market Players
Terumo BCT Inc., Teleflex Incorporated, Haemonetics Corporation, AdvaCare Pharma, Fresenius Kabi USA, Inc., B. Braun of America, Inc., Coloplast Corp., Baxter International Inc., Grifols USA, LLC, Genesis BPS etc. are some of the leading companies operating in the market.Report Scope:
In this report, United States Blood Bags market has been segmented into following categories, in addition to the industry trends which have also been detailed below:United States Blood Bags Market, By Product:
- Single Blood Bag
- Double Blood Bag
- Triple Blood Bag
- Quadruple Blood Bag
- Penta Blood Bag
United States Blood Bags Market, By Type:
- Collection Blood Bags
- Transfer Blood Bags
United States Blood Bags Market, By Volume:
- 450ml
- 350ml
- 150ml
- 100ml
- 250ml
- Others
United States Blood Bags Market, By Material:
- PVC
- PET
- Others
United States Blood Bags Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Blood Banks
- Others
- United States Blood Bags, By Region:
- Mid-West
- South
- North-East
- West
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Blood Bags market
Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.Table of Contents
1. Product Overview2. Research Methodology3. Impact of COVID-19 on United States Blood Bags Market4. Executive Summary10. Market Trends & Developments11. Policy & Regulatory Landscape12. Import-Export Analysis13. United States Economic Profile15. Strategic Recommendations16. About the Publisher & Disclaimer
5. Voice of Customers
6. United States Blood Bags Market Outlook
7. United States Collection Bags Market Outlook
8. United States Transfer Bags Market Outlook
9. Market Dynamics
14. Competitive Landscape
List of Figures
Companies Mentioned
- Terumo BCT Inc.
- Teleflex Incorporated
- Haemonetics Corporation
- AdvaCare Pharma
- Fresenius Kabi USA, Inc.
- B. Braun of America, Inc.
- Coloplast Corp.
- Baxter International Inc.
- Grifols USA, LLC
- Genesis BPS